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Abstract: In the mammalian CNS, aspartate and gluta-
mate are major excitatory amino acids, and their recep-
tors are believed to mediate a wide range of physiological
and pathological processes, including neurotransmis-
sion, plasticity, excitotoxicity, and various forms of neu-
rodegeneration. The immediate early gene pip92 has
been identified in serum-stimulated BALB/c 3T3 fibro-
blasts, activated T lymphocytes treated with cyclohexi-
mide, and fibroblast growth factor-stimulated hippocam-
pal cells during neuronal differentiation. In this study we
have demonstrated that pip92 is expressed in the mouse
brain after a single intraperitoneal injection of NMDA. The
distribution of pip92 mRNA levels in the NMDA-treated
mouse brain was investigated using in situ RT-PCR. The
region-specific activation of pip92 in the CNS was ob-
served 3 h after NMDA injection, and high levels of pip92
mRNA were detected in the hippocampal dentate gyrus
and piriform cortex regions. In addition, the activation of
pip92 by NMDA was mediated by activation of mitogen-
activated protein kinases (MAPKs), such as c-Jun N-
terminal kinase (JNK) and p38 kinase, but not extracellu-
lar signal-regulated kinase (ERK) in the mouse hippocam-
pus and immortalized rat hippocampal progenitor cells.
This study suggests that pip92 is likely to play an impor-
tant role in neuronal cell death induced by excitotoxic
NMDA injury in the CNS. Key Words: NMDA—pip92–
Excitotoxic injury—c-Jun N-terminal kinase—p38—Hip-
pocampus.
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In many cell types, extracellular stimuli such as serum,
growth factors, phorbol esters, neurotransmitters, cyto-
kines, Ca21, UV light, and cellular redox agents regulate
critical cellular events such as growth, differentiation,
and apoptosis through activation of protein kinase cas-
cades. In the brain, excitatory neurotransmission elevates
the calcium concentration in neuronal cells and activates
the transcription of immediate early genes (Ghosh and
Greenberg, 1995). Glutamate and aspartate, the major
excitatory neurotransmitters in the brain, become toxic to
the CNS via excess activation of ionotropic receptors
sensitive to NMDA, kainate, or a-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) (Choi et al.,
1987). Cell death induced by glutamate is believed to be
involved in neuronal loss associated with both acute,
e.g., stroke, and chronic, e.g., Alzheimer’s disease, neu-
rodegenerative insults (Rothman, 1984; Choi and Roth-
man, 1990).
The mitogen-activated protein kinase (MAPK) cas-
cade is considered to be a major signaling pathway that
links signals from the cell surface to the nuclear events
(Hill and Treisman, 1995). This signaling pathway in-
volves transient formation of Ras-GTP, activation of Raf
kinases at the membrane, and sequential activation of
MAPK kinase (MEK) and MAPK/extracellular signal-
regulated kinase (ERK) (Marshall, 1994). Activated
ERKs translocate to the nucleus, phosphorylate, and thus
activate transcription factors such as cyclic AMP re-
sponse element binding protein and Elk1, resulting in the
induction of new gene transcripts. In addition, other
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members of the MAPK superfamily—c-Jun N-terminal
kinase (JNK) and p38—are activated by inflammatory
cytokines and cellular stresses such as UV and high
osmolarity (Kyriakis et al., 1994; Matsuda et al., 1995).
The immediate early gene pip92 (also known as chx1
or ETR101) is rapidly and transiently induced by serum,
platelet-derived growth factor, nerve growth factor, fi-
broblast growth factor, and 12-O-tetradecanoylphorbol
13-acetate and is functionally implicated in the neuronal
differentiation process (Charles et al., 1990; Chung et al.,
1998). pip92 encodes a short-lived, proline-rich protein
with no significant sequence similarity to any known
protein. However, little is known about the function of its
encoded protein. The serum response element (SRE) is
the major regulatory element located in the pip92 pro-
moter, which is recognized by serum response factor
(SRF) and ternary complex factor (TCF), a family of
Ets-domain transcription factors (Latinkic and Lau,
1994). Elk-1 is a member of the TCF family, which is
phosphorylated by ERK and therefore activated to form
a ternary complex with SRF and SRE (Hill and Treis-
man, 1995; Treisman, 1995). Electrophoretic mobility
shift analysis has demonstrated that Elk-1 binds to Ets
sites in the pip92 promoter (Latinkic and Lau, 1994).
JNK and p38, as well as ERK, could also phosphorylate
Elk-1 (Gille et al., 1995; Whitmarsh et al., 1995, 1997;
Janknecht and Hunter, 1997). Although there have been
several reports about situations in which JNK and/or p38
activation occurs without influencing cell death (Liu
et al., 1996; Lenczowski et al., 1997), high levels of JNK
and p38 activities have been correlated with the induc-
tion of apoptosis in many instances (Raitano et al., 1995;
Xia et al., 1995; Chen et al., 1996a,b; Verheij et al.,
1996; Xu et al., 1996; Zanke et al., 1996; Goillot et al.,
1997; Rodrigues et al., 1997; Yang et al., 1997).
Based on these findings, it is possible that JNK and
p38 are involved in pip92 induction during the cell
death process. However, little is known about its role
and the induction mechanism of pip92 in neuronal cell
death induced by cytotoxic stress or neurodegenera-
tive insults. To investigate the role of pip92 in the
cellular response to extracellular cytotoxic stimuli, we
have tested the effect of a systemic administration of
NMDA on pip92 expression in mouse brain and ana-
lyzed the possible signaling pathways involved. Here
we report for the first time that pip92 mRNA levels are
increased in a region-specific manner in mouse CNS
after a single intraperitoneal NMDA injection. Our
results indicate that the activation of p38 and JNK, but
not ERK, is involved in the induction of pip92 during
NMDA-mediated neuronal cell death, suggesting that
different MAPK pathways are involved in expression
of the immediate early gene pip92 induced by growth
factors and excitotoxic stimuli.
EXPERIMENTAL PROCEDURES
Materials
Fetal bovine serum, Dulbecco’s modified Eagle’s medium,
and geneticin were purchased from Life Technologies (Grand
Island, NY, U.S.A.). PD98059 and SB203580 were purchased
from Calbiochem (La Jolla, CA, U.S.A.). (1)-MK-801 maleate,
6-nitro-7-sulfamoylbenzo[ f ]quinoxaline-2,3-dione (NBQX), and
(1R,3R,4S)-1-aminocyclopentane-1,3,4-trichlorocarboxylic
acid (ACPT-II) were purchased from Tocris (Bristol, U.K.).
NMDA and all other chemicals were purchased from Sigma
(St. Louis, MO, U.S.A.). Dominant-negative MEKK (MEK
kinase) and SEK1 (stress-activated protein/ERK kinase 1) mu-
tant, pDMEKK(39)KR-59EE-CMV, pSEK1(AL)/EE-CMV,
and pEE-CMV DNAs were kindly provided by D. Templeton.
Plasmid expressing glutathione S-transferase (GST)–MAPK-
activated protein (MAPKAP) kinase-2 was obtained from C. K.
Huang. Plasmid expressing GST–c-Jun was provided by P.
Angel.
Specimen preparation
Adult ICR mice (weighing 30–35 g) were injected intraperi-
toneally with 70 mg/kg NMDA prepared in phosphate-buffered
saline (pH 7.4) and killed 3 h after treatments as described
elsewhere (Shin et al., 1998). As a control, an equal volume of
vehicle was injected into the mice. The mice were perfused
with phosphate-buffered saline through the heart. Then the
whole brain was removed to prepare for the molecular biolog-
ical and histological investigations. The protocols for animal
experimentation were approved by the Committee on Animal
Care and Experimentation at Kosin University College of Med-
icine. The general molecular biological methods, such as nu-
cleic acid extraction, RT-PCR, and cloning, were performed as
described elsewhere (Ausubel et al., 1995).
Oligonucleotide primers
Based on the sequences of mouse pip92 cDNA (Charles
et al., 1990) and glyceraldehyde-3-phosphate dehydrogenase
(G3PDH) cDNA (Sabath et al., 1990), two sets of oligonucle-
otide primers (59-CTACTCTCGTCGAACAAGCATGGAAG-
39, 59-GCCACCAGAGCTCTCAGAAGGCCACC-39 for pip92;
59-GCCACCCAGAAGACTGTGGATGGC-39, 59-CATGTAG-
GCCATGAGGTCCACCAC-39 for G3DPH) were synthesized
(Bioneer, Korea).
Cell culture and transfection
Rat neuronal hippocampal progenitor H19-7 cells were gen-
erated by transduction with the retroviral vectors containing
temperature-sensitive SV40 large T antigen that is functionally
active at 33°C and inactive at 39°C (Eves et al., 1992). The
H19-7 cells were grown in Dulbecco’s modified Eagle’s me-
dium containing 10% fetal bovine serum and maintained at
33°C under 200 mg/ml G418 selection. Transient transfections
were performed using LipofectAMINE reagents (GibcoBRL)
according to the manufacturer’s protocol. Plasmid pCMV-
GAL, which contains the Escherichia coli b-galactosidase gene
driven by the cytomegalovirus promoter, was used as an inter-
nal control to determine transfection efficiency. When speci-
fied, cells were pretreated with 50 mM noncompetitive NMDA
antagonist [(1)-MK-801], 30 mM selective AMPA/kainate an-
tagonist (NBQX), 100 mM competitive antagonist of the
metabotropic glutamate receptor (ACPT-II), 50 mM synthetic
p38 kinase inhibitor (SB203580), or 30 mM MEK inhibitor
(PD98059) 30 min before NMDA stimulation.
RNA preparations and northern blot analysis
Total cellular RNAs from H19-7 cells were isolated by the
single-step extraction procedure using guanidinium isothiocya-
nate as described elsewhere (Chomczynski and Sacchi, 1987).
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Northern blot analysis to measure pip92 mRNA levels was
done as described previously (Chung et al., 1998).
Assessment of cell survival by 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) extraction assay
Cell survival was quantified by a tetrazolium salt-extraction
method as described elsewhere (Hansen et al., 1989). To each
well containing 250 ml of medium in a 24-well plate, 62.5 ml of
the 5 mg/ml stock solution of MTT was added. After 2 h of
incubation at 37°C, 250 ml of extraction buffer containing 20%
sodium dodecyl sulfate and 50% N,N-dimethyl formamide (pH
7.4) was added. After an overnight incubation at 37°C, the
optical density at 570 nm was measured using a Spectra MAX
340 ELISA Reader (Molecular Devices, Sunnyvale, CA,
U.S.A.), using the extraction buffer as the blank.
In vitro RT-PCR
Total RNA was prepared from the brain using RNAzol B
solution (BIOTEX). The RT conditions were as follows: 4 mg
of total RNA, 4 ml of Moloney murine leukemia virus (M-
MLV) 53 RT buffer, 4 ml of 10 mM deoxynucleotide triphos-
phates, 100 pmol of oligo(dT)16, 20 units of RNasin, 100 units
of M-MLV reverse transcriptase, and RNase-free water to a
total volume of 20 ml. The RT mixture was incubated for 1 h
at 42°C. The PCR conditions were as follows: 1 ml of RT
products, 3 ml of Taq 103 buffer, 1 ml of 10 mM deoxynucle-
otide triphosphates, 10 pmol of sense and antisense primer, 1
unit of Taq polymerase, and deionized water to a total volume
of 30 ml. PCR amplification (30 cycles) was carried out at 94°C
for 30 s, 65°C for 30 s, and 72°C for 30 s.
In situ RT-PCR
Mouse brains were cryosectioned 10 mm thick and mounted
on 3-aminopropyltriethoxysilane-coated slides. Slides were
fixed in 4% paraformaldehyde, washed in phosphate-buffered
saline, and dehydrated in serial concentrations of ethanol.
Genomic DNA was removed using RNase-free DNase (8
U/100 ml). In situ RT mix contained 5 ml of M-MLV 53 RT
buffer, 5 ml of 10 mM deoxynucleotide triphosphates, 100 pmol
of oligo(dT)16, 20 units of RNasin, 100 units of M-MLV
reverse transcriptase, and RNase-free water to a total volume of
25 ml. The section was washed with distilled water and dehy-
drated with 100% ethanol. The slide seal for in situ PCR
(TaKaRa, Japan) was located around the tissue section on the
slide and covered with PCR mixture. In situ PCR mix contained
2.5 ml of Taq 103 buffer, 2.5 ml of 103 PCR dig-labeling mix
(Boehringer Mannheim), 25 pmol of sense and antisense prim-
ers, 2.5 units of Taq polymerase, and deionized water to a total
volume of 25 ml. Cycling conditions were the same as in vitro
PCR conditions. The in situ PCR amplification was carried out
in an OmniGene thermocycler (Hybaid, U.K.), and the products
were visualized using the digoxigenin detection kit (Boehringer
Mannheim). Slides were analyzed using an optical microscope.
Positive-staining cells were purple, whereas negative cells usu-
ally appeared colorless or slightly brown.
Protein kinase assay for ERK, JNK, and p38
Dissected tissues were homogenized using buffer A contain-
ing 20 mM Tris (pH 7.9), 137 mM NaCl, 5 mM Na2EDTA,
10% glycerol, 1.0% Triton X-100, 0.2 mM phenylmethylsul-
fonyl fluoride, 1 mg/ml aprotinin, 20 mM leupeptin, 1 mM
Na3VO4, 1 mM EGTA, 10 mM NaF, 1 mM tetrasodium pyro-
phosphate, and 1 mM b-glycerophosphate. Confluent cells
were harvested and lysed using the same buffer. Cell lysates
were subjected to centrifugation at 12,000 g for 10 min at 4°C.
Soluble fraction was incubated for 1 h at 4°C with antibodies
against JNK1, ERK2, or p38. Immunocomplex kinase assays
were performed as described previously (Chung et al., 1999).
The phosphorylated substrates were visualized by autoradiog-
raphy. Myelin basic protein (Santa Cruz Biotechnology, Santa
Cruz, CA, U.S.A.), GST–c-Jun (kindly provided by Dr. P.
Angel), and GST–MAPKAP kinase-2 (kindly provided by Dr.
C. K. Huang) were used as the substrate for ERK, JNK, and
p38 kinase, respectively. Bacterial GST–fusion proteins were
prepared with the GST purification module (Pharmacia) ac-
cording to the manufacturer’s protocol.
Western blot analysis with anti-ERK, JNK, or p38
antibody
Western blot analysis was performed by using anti-ERK
(Promega, Madison, WI, U.S.A.), anti-JNK (Promega), or anti-
p38 antibody (Santa Cruz), as described previously (Chung
et al., 1999). The MAPK bands were visualized by enhanced
chemiluminescence (Amersham, U.K.).
RESULTS
Single intraperitoneal injection of NMDA induced
an immediate early gene, pip92, in mouse brain
In rats, systemic administration of NMDA was com-
monly used to induce epileptic seizures and excitotoxic
CNS injury (Feigenbaum et al., 1989; Nitsch and
Frotscher, 1992; Metsis et al., 1993; Bing et al., 1997). In
this study we used a single intraperitoneal injection of
convulsive-dosage NMDA to induce excitotoxic injury
in the mouse brain. We have observed that injection of
the same dosage of NMDA induced severe neuronal cell
death in the entire hippocampal region of the CNS (data
not shown). In addition, apoptosis was observed up to 40
days after NMDA injection, and the expression of a few
genes, for example, the immediate early gene c-fos and
c-jun and the apoptosis-related gene Fas/Fas ligand
(FasL), was observed in the hippocampal area (Shin
et al., 1998). To determine the NMDA-induced expres-
sion of pip92 transcripts in the CNS, total RNAs from the
whole brain were prepared at the indicated time after
NMDA injection, and the occurrence of those transcripts
FIG. 1. Induction of mouse brain pip92 mRNA after treatment
with NMDA. After a single intraperitoneal NMDA injection (70
mg/kg), mice were killed at the indicated time, and the total brain
RNAs were extracted. RT-PCR was performed using specific
primer sets of mouse G3PDH as a control for equal RNA loading
(A) and pip92 cDNA (B). Lanes 1, 2, 3, and 4 represent control,
1 h, 2 h, and 3 h after NMDA treatment, respectively. Lane M
represents the 100-bp DNA ladder size marker (Gibco/BRL).
These results are representative of two independent experi-
ments.
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was measured by RT-PCR. As shown in Fig. 1, a single
systemic administration of 70 mg/kg NMDA induced
pip92 gene transcripts in the CNS, and their levels in-
creased in a time-dependent manner for up to 3 h after
addition of NMDA.
Region-specific pip92 induction by NMDA in mouse
CNS
The distribution of pip92 mRNA levels in the NMDA-
treated mouse brain was investigated using in situ RT-
PCR. The region-specific activation of pip92 in the CNS
is shown at 3 h after NMDA injection in Fig. 2. Densely
labeled pip92 messages in the hippocampal dentate gyrus
and moderate signals in the piriform cortex were de-
tected in the NMDA-treated mice (Fig. 2B). Microscopy
with increasing magnification revealed discrete cellular
levels of pip92 labeling in each area. However, the
corresponding brain section of a control mouse did not
show any significant in situ pip92 signal (Fig. 2A).
NMDA induced activation of stress-activated
MAPKs, such as JNK and p38, but not ERK in
mouse hippocampus
To clarify the downstream signaling cascades for the
induction of pip92 in the mouse hippocampus in re-
sponse to NMDA, we isolated hippocampal tissue from
the brain after a single intraperitoneal injection of 70
mg/kg NMDA. Using whole-cell lysates from the hip-
pocampus, we measured the activation of endogenous
ERK, JNK, and p38 by NMDA. As shown in Fig. 3, both
JNK and p38 activities increased from 30 min to 2 h
post-NMDA stimulation. However, we did not detect
any significant levels of ERK activation by NMDA. As a
control for protein loading, we measured the amount of
nonactivated MAPKs by western blot analysis. In all
samples, ERK, JNK, and p38 kinase were present at the
same levels, respectively (data not shown).
JNK- and/or p38-dependent pip92 induction by
NMDA in conditionally immortalized rat
hippocampal H19-7 cells
To confirm the selective activation of p38 and JNK
during the excitotoxic NMDA injury, we tested the effect
of blocking MAPK signaling pathways on NMDA-in-
duced cell death and pip92 induction in neuronal H19-7
cells. The H19-7 cells are derived from embryonic day
17 rat hippocampal cells that have been conditionally
immortalized with temperature-sensitive SV40 large T
antigen (Eves et al., 1992). The chemical inhibitors
PD98059 and SB203580, which can selectively inhibit
the activation of MEK and p38 kinase, respectively, and
FIG. 2. Localization of pip92 mRNA in mouse
brain after a single intraperitoneal injection of
NMDA. At 3 h after a single intraperitoneal injec-
tion of (B) NMDA (70 mg/kg) or (A) vehicle, mice
were killed, and brain sections were prepared
and followed by immunodetection of dig-dUTP-
incorporated and amplified pip92 cDNA. Top left
panel: Gross structure of brain section in a vehi-
cle-injected or vehicle-treated control mouse af-
ter 3 h (A). Top right panel: Gross structure at 3 h
after NMDA treatment (B). Bottom left and right
panels: Micrographs are arranged with increas-
ing order of magnification of enlarged structures
of the piriform cortex region (PC; left) and hip-
pocampal dentate gyrus region (DG; right) of (A)
vehicle-treated control or (B) NMDA-treated
mice, respectively. These results are representa-
tive of two independent experiments.
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kinase-inactive dominant-negative mutant cDNAs in the
JNK signaling cascades, such as SEK1 and MEKK, were
used. We have examined the effect of NMDA on the
viability of H19-7 cells. We observed that treatment of
the H19-7 cells with 100 mM NMDA for 12 h induced
;75% cell death, as measured by the MTT extraction
assay (Table 1). In accordance with the pattern of hip-
pocampal tissue isolated after a systemic NMDA admin-
istration, the same pattern of selective activation of JNK
and p38, but not ERK, was observed by 100 mM NMDA
treatments in the H19-7 cells (data not shown). When 50
mM SB203580 (a p38 kinase inhibitor) was added to the
cells, we observed a complete inhibition of endogenous
p38 activities induced by NMDA (data not shown). As
well, addition of 30 mM MEK inhibitor, PD98059, to the
H19-7 cells was shown to block the basic fibroblast
growth factor-induced activation of ERK completely,
resulting from the inhibition of MEK activity (Kuo et al.,
1997).
Pretreatment of H19-7 cells with 50 mM SB203580
resulted in a significant protection from NMDA-induced
cell death (Table 1). However, when 30 mM PD98059
was added with NMDA, we did not find any significant
inhibition of cell death, compared with that induced by
NMDA alone. Addition of the same concentration of
MEK and p38 kinase inhibitor alone to the cells did not
produce a significant cell death. When we transfected the
H19-7 cells with kinase-inactive dominant-negative mu-
tant SEK1 and MEKK, there was a significant decrease
of cell death, compared with the cells transfected with
the parental control vector alone (pEE-CMV). These data
implied that NMDA-mediated neuronal cell death is me-
diated at least in part by the activation of JNK and p38
kinase, but not ERK. Consistent with the inhibition pat-
tern of NMDA-induced cell death by blocking JNK and
p38 kinase activities, we found that NMDA-induced
pip92 expression in H19-7 cells is also regulated by JNK
and p38 kinase. Northern blot analysis showed that pip92
mRNA levels are induced highly by 100 mM NMDA
(Fig. 4). Induction of pip92 mRNAs by NMDA was
decreased by pretreatment with SB203580 but not
PD98059. In a similar way, transient transfection of
kinase-inactive SEK1 and MEKK cDNAs into the H19-7
cells also produced a significant inhibition of pip92 ex-
FIG. 4. Effect of the inhibition of the MAPKs, ERK, JNK, and p38
on NMDA-induced pip92 expression in rat embryonic hippocam-
pal neuronal H19-7 cells. After pretreatment of H19-7 cells with
50 mM p38 kinase inhibitor [SB203580 (NMDA 1 SB)] or 30 mM
MEK inhibitor [PD98059 (NMDA 1 PD)] for 30 min as indicated,
100 mM NMDA was added and incubated for 3 h. To test the
effect of mutant SEK1 (NMDA 1 mSEK) and MEKK (NMDA
1 mMEKK) on NMDA-induced pip92 expression, 5 mg of the
respective mutant DNAs was transfected into the cells, followed
by addition of 100 mM NMDA for 3 h. Northern blot analysis was
performed to measure pip92 mRNA levels. As a control for equal
RNA loading, total RNAs were hybridized to 32P-labeled G3PDH
cDNA probe. These results are representative of three indepen-
dent experiments.
FIG. 3. Effect of a single intraperitoneal injection of NMDA on
activation of MAPKs in mouse hippocampus. After a single
intraperitoneal NMDA injection (70 mg/kg), mice were killed at
the indicated time, and their hippocampal tissues were dis-
sected. Total cell lysates were prepared, and the protein kinase
activities of ERK, stress-activated protein kinase (SAPK)/JNK,
and p38 kinase were measured by immunoprecipitation using
anti-ERK, anti-JNK1, and anti-p38 antibody followed by an in
vitro solid-phase kinase assay. Myelin basic protein (MBP),
GST–c-Jun, and GST–MAPKAP kinase-2 were used as ERK,
JNK, and p38 substrates, respectively. The numbers at the
bottom of the SAPK/JNK and p38 panels indicate quantitated
values of fold induction measured using a densitometer. These
results are representative of two independent experiments.
TABLE 1. Effect of inhibition of the MAPKs ERK, JNK,
and p38 on NMDA-induced neuronal cell death in
immortalized hippocampal H19-7 cells
Treatment Cell survival (%)
No treatment 100
NMDA 24.4 6 3.6
SB203580 91.2 6 5.7
PD98059 93.2 6 7.1
NMDA 1 SB203580 58.7 6 8.6
NMDA 1 PD98059 26.6 6 5.2
NMDA 1 pCMV 27.8 6 3.9
NMDA 1 mut. MEKK 47.5 6 4.1
NMDA 1 mut. SEK1 53.4 6 6.8
After addition of 50 mM p38 kinase inhibitor (SB203580) or 30 mM
MEK inhibitor (PD98059) to the H19-7 cells for 30 min, 100 mM
NMDA was added and incubated for 12 h. To test the effect of
kinase-inactive SEK1 and MEKK mutants on NMDA-induced cell
death, 5 mg of pEE-CMV (pCMV), pDMEKK(39)KR-59EE-CMV
(mut. MEKK), or pSEK1(AL)/EE-CMV (mut. SEK1) DNAs was tran-
siently transfected into the cells for 24 h using LipofectAMINE, fol-
lowed by addition of 100 mM NMDA for 12 h. Cell viability was
measured by MTT extraction. Results are mean 6 range of data from
three independent experiments done in triplicate.
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pression induced by NMDA, suggesting that p38 and
JNK, but not ERK, are involved in the induction of pip92
during NMDA-mediated neuronal cell death.
NMDA exerts its cytotoxic action through an
ionotropic NMDA receptor subtype in hippocampal
neuronal H19-7 cells
To ensure which subtype of glutamate receptors is
activated during the induction of immediate early gene
pip92 by NMDA in H19-7 cells, we tested the effect of
various selective antagonists of glutamate receptor sub-
types on NMDA-induced cell death. Various NMDA
receptor antagonists, such as the noncompetitive NMDA
antagonist (1)-MK-801, the selective AMPA/kainate an-
tagonist NBQX, and the competitive antagonist of the
metabotropic glutamate receptor ACPT-II, were used to
examine by which receptor subtype the cell death-pro-
moting signals of NMDA are transmitted in the H19-7
cells. When the NMDA-selective MK-801 was pre-
treated for 30 min, the cell death induced by NMDA was
greatly reduced, whereas the AMPA/kainate and the
metabotropic glutamate antagonists did not show any
significant inhibition of NMDA-induced cytotoxicity
(Fig. 5). These data suggest that NMDA exerts its cyto-
toxic effect via the activation of ionotropic glutamate
receptors during the excitotoxic cell death process in
neuronal H19-7 cells.
DISCUSSION
Glutamate receptors have been divided into two major
subtypes: ionotropic and metabotropic glutamate recep-
tors. The ionotropic receptors are further categorized into
NMDA, AMPA, and kainate receptors based on their
agonist names (Watkins et al., 1990). The AMPA/kainate
receptors activate ligand-gated cation channels that are
permeable to Na1 and K1, whereas NMDA receptors are
;10 times more permeable to Ca21 than to Na1. In
many cases, glutamate neurotoxicity, especially later
phases of neuronal degeneration, can be attributed to
excessive stimulation of the NMDA subtype of gluta-
mate receptors (Choi et al., 1988; Ankarcrona et al.,
1995). Pretreatment with the NMDA receptor antagonist
7-aminophosphonoheptanoic acid reduced acute isch-
emic hippocampal damage in vivo (Simon et al., 1984).
Unilateral injections of NMDA (25 nmol/0.5 ml) into
posterior striatum of 7-day-old rats produced consistent
and reproducible lesions characterized by confluent ne-
crosis, gross tissue deformation, and reactive gliosis pre-
dominantly affecting the corpus striatum, dorsal hip-
pocampus, and overlying neocortex in the lesioned hemi-
sphere (McDonald et al., 1990). This pattern of damage
corresponds to NMDA receptor distributions within the
immature brain.
In many studies where the effect of NMDA on the
release of neurotransmitters was examined in vivo, the
substance was applied to a local region through a probe.
This might reflect the fact that it is difficult for NMDA to
penetrate into the CNS because of the blood–brain bar-
rier in adult animals. However, several studies have
indicated that neonatal rodents are particularly sensitive
to systemic administration of excitatory amino acids.
Systemic administration of monosodium glutamate to
neonatal mice led to acute neuronal necrosis in the de-
veloping brain (Olney, 1969). Schoepp et al. (1990)
reported that NMDA administered systemically to im-
mature rats caused motor convulsions that were dimin-
ished by pretreatment with DL-2-amino-5-phosphonova-
leric acid or (6)-3-(2-carboxypiperazin-4-yl)propyl-1-
phosphonic acid, a competitive antagonist of NMDA
receptors. A significant and pronounced increase of the
extracellular taurine level in adult rat hippocampal CA1
and striatum was observed after an intraperitoneal injec-
tion of 10 mg/kg NMDA, whereas a similar effect of
NMDA was also noted when 300 mM NMDA was ap-
plied locally to both regions via probes (Shibanoki et al.,
1993). Systemic applications of kainate and NMDA are
known to induce seizure behavior in rats within 90 min,
followed by severe neuronal cell death in hilar and py-
ramidal neurons of the hippocampus within 3 days (Dra-
gunow and Preston, 1995). A single systemic application
of a convulsive dose of NMDA to mice also results in
both short- and long-term excitotoxic effects on the CNS
(Dragunow and Preston, 1995). These findings suggest
that NMDA administered systemically acts directly on
the specific receptors located in the brain after penetra-
tion through the blood–brain barrier, even if such pene-
tration is strongly restricted by the blood–brain barrier
system. Brace et al. (1997) have shown that both NMDA
and kainate not only damage neurons and myelin but also
compromise the integrity of the blood–brain barrier.
The immediate early gene pip92 (also known as chx1
or ETR101) was independently cloned from serum-stim-
ulated BALB/c 3T3 fibroblasts (Charles et al., 1990) and
activated T lymphocytes treated with cycloheximide
(Coleclough et al., 1990). Human pip92 cDNA was
cloned from the myeloid leukemia cell line HL-60
(Shimizu et al., 1991). pip92 is rapidly and transiently
FIG. 5. Effect of various glutamate receptor subtype antagonists
on NMDA-induced neuronal cell death in rat hippocampal H19-7
cells. After H19-7 cells were pretreated with (1)-MK-801 (50
mM ), NBQX (30 mM ), or ACPT-II (100 mM ) for 30 min, 100 mM
NMDA was added and incubated for 12 h. Cell viability was
measured by MTT extraction. Results are mean 6 range (bars) of
data from three independent experiments.
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induced by stimulation with serum growth factors and
the tumor promoter 12-O-tetradecanoylphorbol 13-ace-
tate in fibroblasts and by treatment with nerve growth
factor or membrane depolarization in PC12 cells
(Charles et al., 1990). The pip92 promoter has been
cloned, and its transcription is induced by serum in
mouse 3T3 fibroblasts via the SRE.
The SRE, studied most extensively in the c-fos pro-
moter, consists of a CArG box that binds to the SRF.
When SRF is bound to the c-fos SRE, it recruits a TCF
to an upstream Ets-like binding site (Hill and Treisman,
1995; Treisman, 1995). In the pip92 promoter, the SRE
consists of at least one Ets protein binding site and a
CArG site. Gel shift analysis demonstrated that the Ets
sites in the pip92 promoter bind to Elk-1 on phosphor-
ylation of two sites, Ser383 and Ser389, by ERKs (Latinkic
and Lau, 1994; Chung et al., 1998). It was shown that,
unlike the c-fos SRE, the pip92 SRE can interact inde-
pendently with Elk-1 without prior formation of the
SRF–DNA binary complex (Latinkic and Lau, 1994;
Latinkic et al., 1996). Recently it has been shown that
Elk-1 is phosphorylated and therefore activated by JNK
and p38, as well as ERK (Gille et al., 1995; Whitmarsh
et al., 1995, 1997). However, it is unclear whether Elk-1
is involved in pip92 induction by NMDA. Recently we
have determined that pip92 is rapidly and transiently
expressed by the translational inhibitor anisomycin in
NIH 3T3 fibroblast cells and that its expression is medi-
ated by the JNK- and p38-dependent activation of Elk-1
(K. C. Chung et al., manuscript in preparation). In addi-
tion to Elk-1, the other family member of the TCF,
Sap-1a, has been reported to be phosphorylated by p38
and involved in c-fos expression through the SRE in
human embryonic kidney 293 cells (Janknecht et al.,
1993). It is also possible that Sap-1 and/or other uniden-
tified members of TCF regulate pip92 expression by
NMDA via its SRE. Answers to these questions will
enhance our understanding of the mechanism of how
mitogenic signals and excitotoxic insults elicit the nu-
clear response.
pip92 encodes a short-lived, proline-rich protein with
no significant sequence similarity with any known pro-
tein. However, to date, little is known about the function
of its encoded protein. Recently, it has been shown that
pip92 is selectively induced by differentiating factors in
rat hippocampal neuronal cells, suggesting that it is a key
component in neuronal differentiation (Chung et al.,
1998). Those studies also reveal the presence of at least
two pathways, one MAPK-dependent and the other
MAPK-independent, for the induction of pip92 in re-
sponse to basic fibroblast growth factor or to activated
Raf-1 in neuronal H19-7 cells. In addition to differenti-
ation, the present study demonstrates that pip92 is likely
to play an important role during the NMDA-induced
excitotoxic injury process. The region-specific induction
of pip92 in the hippocampus is mediated by activation of
the MAPKs JNK and p38, but not ERK, suggesting that
different MAPK pathways are involved in pip92 expres-
sion induced by growth factors and excitotoxic stimuli.
p38 and JNK are known to be involved in cell death
induced by nerve growth factor deprivation in PC12
cells, by ceramide in U937 and BAE cells, and by
anti-IgM antibody in human B lymphocytes (Xia et al.,
1995; Graves et al., 1996; Verheij et al., 1996). In cul-
tured chick fetal forebrain neurons, p38 activity was
down-regulated by insulin, which can help these cells
survive (Heidenreich and Kummer, 1996). Recently, ac-
tivation of p38 kinase has been reported in glutamate-
induced apoptosis in rat cerebellar granule cells, suggest-
ing an essential role of p38 kinase in mediating the
death-promoting activity of glutamate (Kawasaki et al.,
1997). In cultured cortical neurons, ERK activity was
enhanced by stimulation of metabotropic and kainate
types of glutamate receptors but not by stimulation of the
NMDA receptor (Fiore et al., 1993). Consistent with this
finding, by using three different glutamate receptor sub-
type antagonists we have determined that the cytotoxic
effect of 100 mM NMDA is mediated by the activation of
ionotropic NMDA receptor in the H19-7 cells.
Many actions of NMDA are coupled to the influx of
extracellular Ca21 mediated directly or indirectly by its
receptor present in neurons. Transient changes in intra-
cellular Ca21 levels are known to trigger several cellular
responses, including the change of gene expression. We
have observed that treatment of H19-7 cells with thap-
sigargin, which causes Ca21 to leak out of internal stores
and elevates the intracellular Ca21 levels (K. C. Chung
et al., manuscript in preparation), increases the transcrip-
tion of pip92 in neuronal H19-7 cells.
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